Cara Williams is currently the Vice President and Head of Preclinical Biology in the Inflammation & Immunology Research Unit at Pfizer Inc. They previously held the role of Vice President at Boehringer Ingelheim, leading Immunology and Respiratory Disease Research from 2015 to 2019. Prior to that, Cara served in various leadership positions at Pfizer, including Director of Tissue Inflammation and Director of Cell Biology and Pharmacology. Their academic background includes a PhD in Pharmacology from Liverpool University and postdoctoral research at Stanford University and Harvard Medical School, focusing on innate immunity and inflammation.
This person is not in any teams
This person is not in any offices